Ritlecitinib
id:
ritlecitinib-164-3794582
title:
Ritlecitinib
text:
Ritlecitinib (PF-06651600), sold under the brand name Litfulo, is a medication used for the treatment of severe alopecia areata. Ritlecitinib is a kinase inhibitor which inhibits Janus kinase 3 and tyrosine kinase. The most common side effects include headache, diarrhea, acne, rashes, eczema, fever, mouth ulcers, dizziness, shingles rash, and abnormal findings in some laboratory test results. Ritlecitinib was approved for medical use in the United States in June 2023, in the European Union in Se
brand slug:
wiki
category slug:
encyclopedia
description:
Medication to treat hair loss
original url:
https://en.wikipedia.org/wiki/Ritlecitinib
date created:
2023-06-25T05:13:07Z
date modified:
2024-08-28T16:56:32Z
main entity:
{"identifier":"Q120487896","url":"https://www.wikidata.org/entity/Q120487896"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/f0/Ritlecitinib.svg","width":512,"height":394}
fields total:
13
integrity:
16